BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38442976)

  • 1. Congenital adrenal hyperplasia complicated by gonadotropin-dependent precocious puberty.
    Alam A; Agrawal NK; Singh SK
    BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38442976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog.
    Soliman AT; AlLamki M; AlSalmi I; Asfour M
    Metabolism; 1997 May; 46(5):513-7. PubMed ID: 9160816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH; Comite F; Hench K; Barnes K; McNemar A; Foster C; Kenigsberg D; Loriaux DL; Cutler GB
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boy with central precocious puberty probably due to a peripheral cause.
    Sahana PK; Gopal Sankar KS; Sengupta N; Chattopadhyay K
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27256994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes.
    Haddad NG; Eugster EA
    Best Pract Res Clin Endocrinol Metab; 2019 Jun; 33(3):101273. PubMed ID: 31027974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral precocious puberty].
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2009; 60(6):503-14. PubMed ID: 20041371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudo- and central precocious puberty due to adrenogenital syndrome].
    Pouw IS; Drop SL; Ladée-Levy JV; Slijper FM
    Tijdschr Kindergeneeskd; 1986 Jun; 54(3):77-83. PubMed ID: 2944246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and management of abnormal puberty.
    Hopwood NJ
    Spec Top Endocrinol Metab; 1985; 7():175-236. PubMed ID: 3914096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual phenotype of congenital adrenal hyperplasia (CAH) with a novel mutation of the CYP21A2 gene.
    Raisingani M; Contreras MF; Prasad K; Pappas JG; Kluge ML; Shah B; David R
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):867-71. PubMed ID: 27180336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of precocious sexual maturation: an updated review.
    Cheuiche AV; da Silveira LG; de Paula LCP; Lucena IRS; Silveiro SP
    Eur J Pediatr; 2021 Oct; 180(10):3073-3087. PubMed ID: 33745030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorders of childhood growth and development: precocious puberty.
    Chauhan A; Grissom M
    FP Essent; 2013 Jul; 410():25-31. PubMed ID: 23869392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report. An unusual case of precocious puberty.
    Boulware SD
    Curr Opin Pediatr; 1997 Aug; 9(4):443-6. PubMed ID: 9300205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty.
    Güven A; Nurcan Cebeci A; Hancili S
    Hormones (Athens); 2015; 14(2):265-71. PubMed ID: 25553759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess.
    Reiter EO; Grumbach MM; Kaplan SL; Conte FA
    J Clin Endocrinol Metab; 1975 Feb; 40(2):318-25. PubMed ID: 1090842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia.
    Flokas ME; Wakim P; Kollender S; Sinaii N; Merke DP
    J Clin Endocrinol Metab; 2024 Jan; 109(2):498-504. PubMed ID: 37643900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precocious Puberty.
    Banerjee S; Bajpai A
    Indian J Pediatr; 2023 Jun; 90(6):582-589. PubMed ID: 37074536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRH-agonist analogue.
    Dacou-Voutetakis C; Karidis N
    Ann N Y Acad Sci; 1993 May; 687():250-4. PubMed ID: 8323180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.